EUVIMEDEUVIMED entdecken
Vergleichsstudie

Exosome‐Based Therapy: A Comparative Study of Adipose‐ and Umbilical Cord‐Derived Mesenchymal Stem Cells‐Derived Exosomes in Psoriatic Mouse Model

Rueangrit Siriphanit, Wilai Thanasarnaksorn iD, Suphagan Boonpethkaew iD, Saranyoo Ponnikorn, Sasin Charoensuksira, Raksawan Deenonpoe, Punyaphat Sirithanabadeekul, Atchima Suwanchinda iD, Suradej Hongeng iD, Jitlada Meephansan iD

Experimental Dermatology · 2025

DOI: 10.1111/exd.70176 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Experimental Dermatology, 2025. Verfasst von Rueangrit Siriphanit und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dermatology, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand. Hauptthemen laut MEDLINE: Exosomes, Psoriasis, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Chulabhorn International College of Medicine, Chulabhorn International College of Medicine, Thammasat University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Exosomes are nanosized extracellular vesicles that mediate intercellular communication by transferring bioactive molecules. Mesenchymal stem cells (MSCs) from different tissue sources secrete exosomes with potentially distinct therapeutic properties. In this study, we compared the anti‐inflammatory efficacy of exosomes derived from human adipose‐derived MSCs (hADMSCs‐EXOs) and human umbilical cord‐derived MSCs (hUCMSCs‐EXOs), together with desoximetasone (DSM), in an imiquimod‐induced psoriasis mouse model. Psoriasiform lesions were induced, and treatment outcomes were assessed through clinical, histological, and immunological assessments. Both hADMSCs‐EXOs and hUCMSCs‐EXOs significantly attenuated psoriasiform lesions, as clinically evidenced by reduced cumulative Psoriasis Severity Index (PSI) scores by day 6 of treatment. Notably, hUCMSCs‐EXOs and DSM significantly reduced epidermal and dermal thickness to no significant difference compared to the control group. Immune cell infiltration, including CD3 + , CD4 + , CD8 + T cells, CD68 + macrophages, CD117 + mast cells, and neutrophils, was also markedly reduced in the hUCMSCs‐EXOs and DSM groups. Importantly, unlike DSM, hUCMSCs‐EXOs did not induce skin thinning or systemic adverse effects. Growth factor (GF) profiling revealed that hADMSCs‐EXOs were enriched in FGFs, PDGFs, and VEGF, whereas hUCMSCs‐EXOs contained higher levels of HGF, a key modulator of immunoregulation and tissue repair. Collectively, these findings suggest that MSC‐derived exosomes exert therapeutic effects through both anti‐inflammatory and regenerative mechanisms, with hUCMSCs‐EXOs demonstrating superior anti‐inflammatory efficacy over hADMSCs‐EXOs and a lower likelihood of inducing local or systemic adverse effects compared with DSM. Given the influence of MSC tissue origin on exosome content and function, our results support the potential of hUCMSCs‐EXOs as a promising steroid‐sparing therapeutic approach for psoriasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesPsoriasisMesenchymal Stem CellsMesenchymal Stem Cell TransplantationAnimalsHumansUmbilical CordDisease Models, AnimalAdipose TissueMiceImiquimodFemale

Stichwörter der Autor:innen

exosomesgrowth factorsimiquimod‐induced mouse modelinflammationpsoriasis

Substanzen

Imiquimod

Autor:innen und Institutionen

  • Division of Dermatology, Chulabhorn International College of Medicine, Thammasat University, Pathum Thani, Thailand.
  • Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Thammasat University, Pattaya Campus, Chonburi, Thailand.
  • Department of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Cholangiocarcinoma Research Institute (CARI), Khon Kaen University, Khon Kaen, Thailand.
  • Division of Hematology, Department of Pediatric, Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand.

ORCID-Profile: Wilai Thanasarnaksorn, Suphagan Boonpethkaew, Atchima Suwanchinda, Suradej Hongeng, Jitlada Meephansan

Förderung

  • Chulabhorn International College of Medicine
  • Chulabhorn International College of Medicine, Thammasat University

Zitieren

APA

Siriphanit, R., Thanasarnaksorn, W., Boonpethkaew, S., Ponnikorn, S., Charoensuksira, S., Deenonpoe, R., Sirithanabadeekul, P., Suwanchinda, A., Hongeng, S., & Meephansan, J. (2025). Exosome‐Based Therapy: A Comparative Study of Adipose‐ and Umbilical Cord‐Derived Mesenchymal Stem Cells‐Derived Exosomes in Psoriatic Mouse Model. Experimental Dermatology. https://doi.org/10.1111/exd.70176

Vancouver

Siriphanit R, Thanasarnaksorn W, Boonpethkaew S, Ponnikorn S, Charoensuksira S, Deenonpoe R, et al. Exosome‐Based Therapy: A Comparative Study of Adipose‐ and Umbilical Cord‐Derived Mesenchymal Stem Cells‐Derived Exosomes in Psoriatic Mouse Model. Experimental Dermatology. 2025. doi:10.1111/exd.70176

BibTeX
@article{Siriphanit2025,
  author = {Siriphanit, Rueangrit and Thanasarnaksorn, Wilai and Boonpethkaew, Suphagan and Ponnikorn, Saranyoo and Charoensuksira, Sasin and Deenonpoe, Raksawan and Sirithanabadeekul, Punyaphat and Suwanchinda, Atchima and Hongeng, Suradej and Meephansan, Jitlada},
  title = {Exosome‐Based Therapy: A Comparative Study of Adipose‐ and Umbilical Cord‐Derived Mesenchymal Stem Cells‐Derived Exosomes in Psoriatic Mouse Model},
  journal = {Experimental Dermatology},
  year = {2025},
  doi = {10.1111/exd.70176}
}
Kostenlos starten →